Daniel Wojdyla

Active 2004–2026

115
Papers
22,931
Citations
68
h-index
100
i10-index

Citations

Citations per year for Daniel Wojdyla2003: 2 citations2004: 1 citations2005: 3 citations2006: 18 citations2007: 44 citations2008: 53 citations2009: 60 citations2010: 106 citations2011: 154 citations2012: 154 citations2013: 218 citations2014: 221 citations2015: 207 citations2016: 179 citations2017: 199 citations2018: 163 citations2019: 578 citations2020: 655 citations2021: 581 citations2022: 405 citations2023: 306 citations2024: 510 citations2025: 253 citations2026: 10 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,805 citing papers, 18.1% of this breakdownUnited Kingdom: 889 citing papers, 8.9% of this breakdownCanada: 501 citing papers, 5% of this breakdownItaly: 490 citing papers, 4.9% of this breakdownChina: 430 citing papers, 4.3% of this breakdownGermany: 389 citing papers, 3.9% of this breakdownNetherlands: 338 citing papers, 3.4% of this breakdownAustralia: 335 citing papers, 3.4% of this breakdownFrance: 304 citing papers, 3.1% of this breakdownSwitzerland: 283 citing papers, 2.8% of this breakdownSweden: 273 citing papers, 2.7% of this breakdownSpain: 227 citing papers, 2.3% of this breakdown
0%18.1%Other 37.2%

Fields

  • Medicine88.1%
  • Nursing2.3%
  • Biochemistry, Genetics and Molecular Biology2.2%
  • Health Professions1.4%
  • Environmental Science1%
  • Agricultural and Biological Sciences0.9%
  • Other4.1%

Topics

  • Atrial Fibrillation Management and Outcomes6.3%
  • Pregnancy and preeclampsia studies4.9%
  • Antiplatelet Therapy and Cardiovascular Diseases3.4%
  • Maternal and fetal healthcare3.4%
  • Global Maternal and Child Health3.3%
  • Iron Metabolism and Disorders3.2%
  • Other75.5%

Coauthors

All papers

Open in search
  1. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993–2005

    Authors: , , , , - Public Health Nutrition 2008 cited by 2,744

  2. WHO analysis of causes of maternal death: a systematic review

    Authors: , , , , - The Lancet 2006 cited by 4,027

  3. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel Wojdyla, Christopher B. Granger - Circulation 2022 cited by 369

  4. Quantifying Importance of Major Risk Factors for Coronary Heart Disease

    Authors: , , , , , , , , - Circulation 2019 cited by 245

  5. Predictive Accuracy of Stroke Risk Prediction Models Across Black and White Race, Sex, and Age Groups

    Authors: , , , , , , , , , , , , - JAMA 2023 cited by 94

  6. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity

    Authors: , , , , , , , , - Bulletin of the World Health Organization 2009 cited by 2,151

  7. Graft Failure After Coronary Artery Bypass Grafting and Its Association With Patient Characteristics and Clinical Events: A Pooled Individual Patient Data Analysis of Clinical Trials With Imaging Follow-Up

    Authors: , , , , , , , , , , , , , , , , , , , , , - Circulation 2023 cited by 101

  8. Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease

    Authors: , , , , , , , , , , , - Circulation 2020 cited by 164

  9. The association between triglycerides and incident cardiovascular disease: What is “optimal”?

    Authors: , , , , , , , - Journal of clinical lipidology 2020 cited by 119

  10. Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2024 cited by 69

  11. Digoxin and Mortality in Patients With Atrial Fibrillation

    Authors: , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2018 cited by 213

  12. Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention

    Authors: , , , , , , , , , - Circulation 2020 cited by 130

  13. Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment

    Authors: , , , , , , , , , , , - European Heart Journal 2011 cited by 614

  14. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?

    Authors: , , , , , , , , , , , , , - American Journal of Obstetrics and Gynecology 2006 cited by 466

  15. Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin

    Authors: , , , , , , , , , , , , - Journal of the American College of Cardiology 2014 cited by 341

  16. Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL)

    Authors: , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2017 cited by 120

  17. Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis

    Authors: , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2019 cited by 89

  18. Maternal and neonatal individual risks and benefits associated with caesarean delivery: multicentre prospective study

    Authors: , , , , , , , , , , , , , , , , , , - BMJ 2007 cited by 692

  19. The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2014 cited by 126

  20. Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

    Authors: , , , , , , , , , , , , , - The Lancet Neurology 2012 cited by 284

  21. Ticagrelor Versus Clopidogrel in Elderly Patients With Acute Coronary Syndromes

    Authors: , , , , , , , , , , , , , , - Circulation Cardiovascular Quality and Outcomes 2012 cited by 231

  22. Outcomes of PCI in Relation to Procedural Characteristics and Operator Volumes in the United States

    Authors: , , , , , , , , , , , - Journal of the American College of Cardiology 2017 cited by 152

  23. Stent Thrombosis in Patients With Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial

    Authors: , , , , , , , , , , , , , , - Circulation 2019 cited by 117

  24. Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

    Authors: , , , , , , , , , , , , , , , , , - Journal of the American Heart Association 2015 cited by 97